| 期 |
栏目 |
标题 |
文件 |
| 卷 92, 编号 6 (2020) |
Consensuns |
The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndrome |
(Rus)
|
| 卷 92, 编号 7 (2020) |
Original articles |
Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
Vascular remodeling with violations of intracardiac hemodynamics in patients older age category, combined with the clinical-cluster, neurocognitive and biomarker heterogeneity in multifocal atherosclerosis |
(Rus)
|
| 卷 93, 编号 11 (2021) |
Original articles |
Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus |
(Rus)
|
| 卷 94, 编号 7 (2022) |
Reviews |
Problems associated with effective pharmacotherapy of the elderly patients (geriatrics): A review |
(Rus)
|
| 卷 94, 编号 10 (2022) |
Original articles |
Body composition in sarcopenia in middle-aged individuals |
(Rus)
|
| 卷 94, 编号 8 (2022) |
Reviews |
Modern extemporaneous formulations in the geriatric care management: current opportunities and future challenges. A review |
(Rus)
|
| 卷 95, 编号 3 (2023) |
Reviews |
Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Reviews |
Structural and functional characteristics of the brain and their role in the development of eating behaviour in obesity: A review |
(Rus)
|
| 卷 95, 编号 8 (2023) |
Reviews |
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review |
(Rus)
|
| 卷 95, 编号 12 (2023) |
Original articles |
Predictive capability of Cys112Arg single nucleotide polymorphisms of the apolipoprotein E gene in assessing the risk of immediate and early post-traumatic seizures |
(Rus)
|
| 卷 96, 编号 1 (2024) |
Reviews |
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review |
(Rus)
|
| 卷 96, 编号 3 (2024) |
Original articles |
Features of type 2 diabetes mellitus and its pharmacotherapy in outpatients |
(Rus)
|
| 卷 96, 编号 4 (2024) |
Reviews |
Status and trends of legislative and regulatory regulation of off-label use of drugs: A review |
(Rus)
|
